search
Back to results

Robot-Enhanced Stroke Therapy Optimizes Rehabilitation (RESTORE) (RESTORE)

Primary Purpose

Stroke

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Robotic exoskeleton
Usual Care
Sponsored by
University of Calgary
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke, Stroke Rehabilitation, Robotic Exoskeleton

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Recent first stroke (ischemic or hemorrhagic)
  • Upper extremity Fugl-Meyer score 15-45
  • Modified Ashworth score of shoulder/elbow less than or equal to 2
  • Able to follow task instructions
  • Visual acuity better than 20/50 in both eyes
  • Able to give consent
  • Able to commit to follow-up

Exclusion Criteria:

  • Prior stroke or significant neurologic problem (e.g. Multiple Sclerosis)
  • Pre-existing musculoskeletal injury that will interfere with active therapy
  • Pre-Stroke Modified Rankin Score > 2
  • Clinical evidence of Unilateral Spatial Neglect on the Behavioural Inattention Test (BIT)
  • Enrollment in a concurrent clinical intervention trial
  • Major co-morbid or concurrent illness such that improvement is unlikely or completion of the protocol as specified is unlikely

Sites / Locations

  • Foothills HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

Early Robotic Rehab Low Intensity

Early Robotic Rehab High Intensity

Late Robotic Rehab Low Intensity

Late Robotic Rehab High Intensity

Control Group

Arm Description

This group will begin robotic rehabilitation using a robotic exoskeleton between days 5-9 after their stroke. They will receive one hour of treatment per day for 20 days.

This group will begin robotic rehabilitation using a robotic exoskeleton between days 5-9 after their stroke. They will receive 2 one-hour treatment sessions per day for 20 days.

This group will begin robotic rehabilitation using a robotic exoskeleton between days 21-25 after their stroke. They will receive one hour of treatment per day for 20 days.

This group will begin robotic rehabilitation using a robotic exoskeleton between days 21-25 after their stroke. They will receive 2 one-hour treatment sessions per day for 20 days.

This group will receive usual care with robotic assessment.

Outcomes

Primary Outcome Measures

Change in Fugl-Meyer upper extremity motor function score (FMA)
FMA scores upper extremity motor impairment based on 22 items and scores range from 0 (completely plegic) to 66 (normal).

Secondary Outcome Measures

Functional Independence Measure (FIM)
FIM rates subjects on 18 items across many functions such as eating, grooming, bathing and dressing on a scale from 1 (total assistance needed) to 7 (complete independence). Lowest possible score is 18 (lowest independence) and the best possible score is 126 (completely independent). The FIM is the standard measure used by rehabilitation facilities in Cananda and the United States to evaluate overall function and burden of care.
modified Rankin Scale (mRS)
The mRS is a disability rating scale from 0 (no symptoms at all) to 6 (deceased).
Action Research Arm Test (ARAT)
The ARAT assesses arm function to determine the quality of the arm movement, and the limitation of activity. The ARAT consists of 4 sub-tests; that examines and individual's grip, grasp, pinch and gross motor movement in order to determine upper extremity function. Objects of varying size, shape, and weight must be either grasped, handled or moved in a specific task in order to evaluate function. Low scores mean worse function with the minimum possible score being 0 and the highest possible score being 57 (normal function).
Robotic Assessments
Robotic Assessments. The robotic assessment consists of a number of upper limb tests of neurologic function which have been validated against standard clinical measures. Tasks include: Range of Motion, Visually Guided Reaching, Limb Position Matching, Limb Kinesthesia, and Object Hit. These assessments use z-scores, based on normal distributions, as a measure of performance. Scores within 1.96 standard deviations away from 0 are considered normal and scores beyond 1.96 standard deviations are considered impaired.

Full Information

First Posted
December 13, 2019
Last Updated
December 19, 2019
Sponsor
University of Calgary
Collaborators
Queen's University
search

1. Study Identification

Unique Protocol Identification Number
NCT04201613
Brief Title
Robot-Enhanced Stroke Therapy Optimizes Rehabilitation (RESTORE)
Acronym
RESTORE
Official Title
Robot-Enhanced Stroke Therapy Optimized Rehabilitation
Study Type
Interventional

2. Study Status

Record Verification Date
December 2019
Overall Recruitment Status
Unknown status
Study Start Date
May 1, 2019 (Actual)
Primary Completion Date
October 2022 (Anticipated)
Study Completion Date
October 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Calgary
Collaborators
Queen's University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate two aspects of robotic therapy after stroke. One goal is to determine if early robotic rehabilitation of the upper limb (beginning 5-9 days post-stroke) is more effective than later robotic rehabilitation (beginning 21-25 days post-stroke). The other goal is to determine if higher intensity robotic rehabilitation (2 hours/day) is more effective than lower intensity robotic rehabilitation (1 hour/day).
Detailed Description
Medically stable stroke subjects will be recruited in the first few days following their stroke. All participants will complete clinical and robotic assessments of neurologic function at 7 time points. Therapy will occur daily (Monday through Friday) for 20 days. Study participants will be randomly assigned to 1) start robot therapy early or late after stroke and 2)receive one or two hours of robot therapy per treatment day for four weeks, or 3) control group that will receive the current standard of care. The participant's chart will be reviewed for information about their stroke and related health effects and medical treatments. Assessment points to track progress will occur at 7, 18, 31,44,90,180, and 365 days after a stroke for all groups (give or take 2 days to account for weekends and holidays). Standard clinical assessments of neurologic function will be done at each assessment point and include: cognition, arm strength, muscle tone, spasticity, reflexes, dexterity, visual acuity and fields, the Behavioural Inattention Test, and tests of arm movement (Fugl-Meyer Upper-Extremity, Box and Block Test, Chedoke-McMaster Stroke Assessment, and the Action Research Arm Test). These assessments can usually be done in about an hour. The assessment may be done over two sessions if needed due to fatigue or scheduling conflicts. Robotic therapy will be conducted using the Kinesiological Instrument for Normal and Altered Reaching Movements (KINARM, Bkin Technologies, Kingston, ON). It will include several different tasks, each designed to train aspects of sensorimotor function of the proximal upper limb. Task performance will be monitored and difficulty will increase within and between sessions. The majority of the investigator's methods have been used previously to achieve equivalent or superior outcomes to standard rehabilitation. Robotic assessment will measure elbow and shoulder range of motion, reaching for targets, the ability to mirror match the position of an arm with the other arm, and the ability to use both arms to hit away moving targets. The robotic assessment will take approximately 1.5 hours. Robotic tasks include: Visually guided reaching with assistance or resistance; Virtual Soccer; Shape Tracking; Whack-a-mole; Table Tennis Task; Ball on Bar Task; Proprioceptive Reaching; Hand Ball; Proprioceptive Shape Tracking.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Stroke, Stroke Rehabilitation, Robotic Exoskeleton

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
132 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Early Robotic Rehab Low Intensity
Arm Type
Active Comparator
Arm Description
This group will begin robotic rehabilitation using a robotic exoskeleton between days 5-9 after their stroke. They will receive one hour of treatment per day for 20 days.
Arm Title
Early Robotic Rehab High Intensity
Arm Type
Active Comparator
Arm Description
This group will begin robotic rehabilitation using a robotic exoskeleton between days 5-9 after their stroke. They will receive 2 one-hour treatment sessions per day for 20 days.
Arm Title
Late Robotic Rehab Low Intensity
Arm Type
Active Comparator
Arm Description
This group will begin robotic rehabilitation using a robotic exoskeleton between days 21-25 after their stroke. They will receive one hour of treatment per day for 20 days.
Arm Title
Late Robotic Rehab High Intensity
Arm Type
Active Comparator
Arm Description
This group will begin robotic rehabilitation using a robotic exoskeleton between days 21-25 after their stroke. They will receive 2 one-hour treatment sessions per day for 20 days.
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
This group will receive usual care with robotic assessment.
Intervention Type
Device
Intervention Name(s)
Robotic exoskeleton
Other Intervention Name(s)
KINARM
Intervention Description
The Kinesiological Instrument for Normal and Altered Reaching Movements (KINARM) robotic exoskeleton used to provide therapy and assessment. The device has framework that supports the arms and the supports are adjustable to ensure a comfortable fit. Motors attached to the framework record shoulder and elbow movements and also move the arms.
Intervention Type
Behavioral
Intervention Name(s)
Usual Care
Intervention Description
This group will receive standard care with no additional therapy.
Primary Outcome Measure Information:
Title
Change in Fugl-Meyer upper extremity motor function score (FMA)
Description
FMA scores upper extremity motor impairment based on 22 items and scores range from 0 (completely plegic) to 66 (normal).
Time Frame
From baseline to 44 days
Secondary Outcome Measure Information:
Title
Functional Independence Measure (FIM)
Description
FIM rates subjects on 18 items across many functions such as eating, grooming, bathing and dressing on a scale from 1 (total assistance needed) to 7 (complete independence). Lowest possible score is 18 (lowest independence) and the best possible score is 126 (completely independent). The FIM is the standard measure used by rehabilitation facilities in Cananda and the United States to evaluate overall function and burden of care.
Time Frame
From baseline to 180 days
Title
modified Rankin Scale (mRS)
Description
The mRS is a disability rating scale from 0 (no symptoms at all) to 6 (deceased).
Time Frame
From baseline to 180 days
Title
Action Research Arm Test (ARAT)
Description
The ARAT assesses arm function to determine the quality of the arm movement, and the limitation of activity. The ARAT consists of 4 sub-tests; that examines and individual's grip, grasp, pinch and gross motor movement in order to determine upper extremity function. Objects of varying size, shape, and weight must be either grasped, handled or moved in a specific task in order to evaluate function. Low scores mean worse function with the minimum possible score being 0 and the highest possible score being 57 (normal function).
Time Frame
From baseline to 180 days
Title
Robotic Assessments
Description
Robotic Assessments. The robotic assessment consists of a number of upper limb tests of neurologic function which have been validated against standard clinical measures. Tasks include: Range of Motion, Visually Guided Reaching, Limb Position Matching, Limb Kinesthesia, and Object Hit. These assessments use z-scores, based on normal distributions, as a measure of performance. Scores within 1.96 standard deviations away from 0 are considered normal and scores beyond 1.96 standard deviations are considered impaired.
Time Frame
From baseline to 180 days.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Recent first stroke (ischemic or hemorrhagic) Upper extremity Fugl-Meyer score 15-45 Modified Ashworth score of shoulder/elbow less than or equal to 2 Able to follow task instructions Visual acuity better than 20/50 in both eyes Able to give consent Able to commit to follow-up Exclusion Criteria: Prior stroke or significant neurologic problem (e.g. Multiple Sclerosis) Pre-existing musculoskeletal injury that will interfere with active therapy Pre-Stroke Modified Rankin Score > 2 Clinical evidence of Unilateral Spatial Neglect on the Behavioural Inattention Test (BIT) Enrollment in a concurrent clinical intervention trial Major co-morbid or concurrent illness such that improvement is unlikely or completion of the protocol as specified is unlikely
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mark Piitz, BSc
Phone
403-944-4050
Email
mark.piitz@albertahealthservices.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sean Dukelow, MD, PhD
Organizational Affiliation
University of Calgary
Official's Role
Principal Investigator
Facility Information:
Facility Name
Foothills Hospital
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N2T9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sean Dukelow, MD PhD
Phone
4039445930
Email
spdukelo@ucalgary.ca

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
10822433
Citation
Volpe BT, Krebs HI, Hogan N, Edelstein OTR L, Diels C, Aisen M. A novel approach to stroke rehabilitation: robot-aided sensorimotor stimulation. Neurology. 2000 May 23;54(10):1938-44. doi: 10.1212/wnl.54.10.1938.
Results Reference
background
PubMed Identifier
12690583
Citation
Fasoli SE, Krebs HI, Stein J, Frontera WR, Hogan N. Effects of robotic therapy on motor impairment and recovery in chronic stroke. Arch Phys Med Rehabil. 2003 Apr;84(4):477-82. doi: 10.1053/apmr.2003.50110.
Results Reference
background
PubMed Identifier
19794134
Citation
Dukelow SP, Herter TM, Moore KD, Demers MJ, Glasgow JI, Bagg SD, Norman KE, Scott SH. Quantitative assessment of limb position sense following stroke. Neurorehabil Neural Repair. 2010 Feb;24(2):178-87. doi: 10.1177/1545968309345267. Epub 2009 Sep 30.
Results Reference
background
PubMed Identifier
14663051
Citation
Ferraro M, Palazzolo JJ, Krol J, Krebs HI, Hogan N, Volpe BT. Robot-aided sensorimotor arm training improves outcome in patients with chronic stroke. Neurology. 2003 Dec 9;61(11):1604-7. doi: 10.1212/01.wnl.0000095963.00970.68.
Results Reference
background
PubMed Identifier
16680610
Citation
Daly JJ, Hogan N, Perepezko EM, Krebs HI, Rogers JM, Goyal KS, Dohring ME, Fredrickson E, Nethery J, Ruff RL. Response to upper-limb robotics and functional neuromuscular stimulation following stroke. J Rehabil Res Dev. 2005 Nov-Dec;42(6):723-36. doi: 10.1682/jrrd.2005.02.0048.
Results Reference
background
PubMed Identifier
16586194
Citation
Finley MA, Fasoli SE, Dipietro L, Ohlhoff J, Macclellan L, Meister C, Whitall J, Macko R, Bever CT Jr, Krebs HI, Hogan N. Short-duration robotic therapy in stroke patients with severe upper-limb motor impairment. J Rehabil Res Dev. 2005 Sep-Oct;42(5):683-92. doi: 10.1682/jrrd.2004.12.0153.
Results Reference
background
PubMed Identifier
18184932
Citation
Volpe BT, Lynch D, Rykman-Berland A, Ferraro M, Galgano M, Hogan N, Krebs HI. Intensive sensorimotor arm training mediated by therapist or robot improves hemiparesis in patients with chronic stroke. Neurorehabil Neural Repair. 2008 May-Jun;22(3):305-10. doi: 10.1177/1545968307311102. Epub 2008 Jan 9.
Results Reference
background
PubMed Identifier
20400552
Citation
Lo AC, Guarino PD, Richards LG, Haselkorn JK, Wittenberg GF, Federman DG, Ringer RJ, Wagner TH, Krebs HI, Volpe BT, Bever CT Jr, Bravata DM, Duncan PW, Corn BH, Maffucci AD, Nadeau SE, Conroy SS, Powell JM, Huang GD, Peduzzi P. Robot-assisted therapy for long-term upper-limb impairment after stroke. N Engl J Med. 2010 May 13;362(19):1772-83. doi: 10.1056/NEJMoa0911341. Epub 2010 Apr 16. Erratum In: N Engl J Med. 2011 Nov 3;365(18):1749.
Results Reference
background
PubMed Identifier
21840917
Citation
Liao WW, Wu CY, Hsieh YW, Lin KC, Chang WY. Effects of robot-assisted upper limb rehabilitation on daily function and real-world arm activity in patients with chronic stroke: a randomized controlled trial. Clin Rehabil. 2012 Feb;26(2):111-20. doi: 10.1177/0269215511416383. Epub 2011 Aug 12.
Results Reference
background
PubMed Identifier
21148439
Citation
Cumming TB, Thrift AG, Collier JM, Churilov L, Dewey HM, Donnan GA, Bernhardt J. Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke. 2011 Jan;42(1):153-8. doi: 10.1161/STROKEAHA.110.594598. Epub 2010 Dec 9.
Results Reference
background
PubMed Identifier
20131942
Citation
Hu MH, Hsu SS, Yip PK, Jeng JS, Wang YH. Early and intensive rehabilitation predicts good functional outcomes in patients admitted to the stroke intensive care unit. Disabil Rehabil. 2010;32(15):1251-9. doi: 10.3109/09638280903464448.
Results Reference
background
PubMed Identifier
21674387
Citation
Scott SH, Dukelow SP. Potential of robots as next-generation technology for clinical assessment of neurological disorders and upper-limb therapy. J Rehabil Res Dev. 2011;48(4):335-53. doi: 10.1682/jrrd.2010.04.0057.
Results Reference
background
PubMed Identifier
24193800
Citation
Semrau JA, Herter TM, Scott SH, Dukelow SP. Robotic identification of kinesthetic deficits after stroke. Stroke. 2013 Dec;44(12):3414-21. doi: 10.1161/STROKEAHA.113.002058. Epub 2013 Nov 5.
Results Reference
background
PubMed Identifier
33478563
Citation
Keeling AB, Piitz M, Semrau JA, Hill MD, Scott SH, Dukelow SP. Robot enhanced stroke therapy optimizes rehabilitation (RESTORE): a pilot study. J Neuroeng Rehabil. 2021 Jan 21;18(1):10. doi: 10.1186/s12984-021-00804-8.
Results Reference
derived

Learn more about this trial

Robot-Enhanced Stroke Therapy Optimizes Rehabilitation (RESTORE)

We'll reach out to this number within 24 hrs